Related Experiment Video
Updated: May 4, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Tissue penetration of antifungal agents
Timothy Felton1, Peter F Troke, William W Hope
1The University of Manchester, Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Abstract:
Understanding the tissue penetration of systemically administered antifungal agents is critical for a proper appreciation of their antifungal efficacy in animals and humans. Both the time course of an antifungal drug and its absolute concentrations within tissues may differ significantly from those observed in the bloodstream. In addition, tissue concentrations must also be interpreted within the context of the pathogenesis of the various invasive fungal infections, which differ significantly. There are major technical obstacles to the estimation of concentrations of antifungal agents in various tissue subcompartments, yet these agents, even those within the same class, may exhibit markedly different tissue distributions. This review explores these issues and provides a summary of tissue concentrations of 11 currently licensed systemic antifungal agents. It also explores the therapeutic implications of their distribution at various sites of infection.
Insights
Systemic antifungal drug concentrations in tissues, not just blood, are key for effective treatment. This review details drug distribution and therapeutic implications for invasive fungal infections.
Area of Science:
- Pharmacology
- Mycology
- Infectious Diseases
Background:
- Antifungal efficacy depends on tissue drug penetration, which can differ from blood levels.
- Invasive fungal infections have varied pathogenesis, influencing drug concentration interpretation.
- Estimating antifungal concentrations in tissue subcompartments presents technical challenges.
Purpose of the Study:
- To review tissue penetration and distribution of systemic antifungal agents.
- To summarize tissue concentrations of 11 licensed systemic antifungal drugs.
- To explore therapeutic implications of antifungal drug distribution in various infection sites.
Main Methods:
- Literature review of systemic antifungal agents.
- Analysis of pharmacokinetic data focusing on tissue distribution.
- Synthesis of information on 11 currently licensed systemic antifungal agents.
Main Results:
- Systemic antifungal agents exhibit diverse tissue distribution patterns.
- Tissue concentrations and their time course can significantly deviate from plasma concentrations.
- Understanding drug distribution is crucial for optimizing antifungal therapy.
Conclusions:
- Tissue penetration is a critical factor in antifungal drug efficacy.
- Variability in tissue distribution impacts treatment strategies for invasive fungal infections.
- Further research into antifungal drug tissue pharmacokinetics is warranted.
Related Concept Videos
Antifungal Agents
Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Antimicrobial Effectiveness
Bioavailability Enhancement: Drug Permeability Enhancement
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...

